{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:23:56Z","timestamp":1790735036045,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research (MEMK)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY24625"],"award-info":[{"award-number":["EY24625"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY24717"],"award-info":[{"award-number":["EY24717"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.prostaglandins.2018.09.004","type":"journal-article","created":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T21:20:02Z","timestamp":1537132802000},"page":"54-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Inflammation and CB2 signaling drive novel changes in the ocular lipidome and regulate immune cell activity in the eye"],"prefix":"10.1016","volume":"139","author":[{"given":"J.T.","family":"Toguri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Leishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Szczesniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.B.","family":"Laprairie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Oehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Straiker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.M.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.B.","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.prostaglandins.2018.09.004_bib0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/MD.0b013e31817b0747","article-title":"High prevalence of fastidious bacteria in 1520 cases of uveitis of unknown etiology","volume":"87","author":"Drancourt","year":"2008","journal-title":"Medicine"},{"issue":"9","key":"10.1016\/j.prostaglandins.2018.09.004_bib0010","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/bjo.80.9.844","article-title":"The possible impact of uveitis in blindness: a literature survey","volume":"80","author":"Suttorp-Schulten","year":"1996","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.09.004_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ddmod.2006.03.005","article-title":"Animal models of autoimmune and immune-mediated uveitis","volume":"3","author":"Caspi","year":"2006","journal-title":"Drug Discov. Today Dis. Models"},{"issue":"3-4","key":"10.1016\/j.prostaglandins.2018.09.004_bib0020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000119871","article-title":"Mouse models of experimental autoimmune uveitis","volume":"40","author":"Caspi","year":"2008","journal-title":"Ophthalmic Res."},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.09.004_bib0025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1590\/S0004-27492012000200016","article-title":"Experimental models of autoimmune inflammatory ocular diseases","volume":"75","author":"Gasparin","year":"2012","journal-title":"Arq. Bras. Oftalmol."},{"issue":"6","key":"10.1016\/j.prostaglandins.2018.09.004_bib0030","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/bph.12545","article-title":"Anti\u2010inflammatory effects of cannabinoid CB2 receptor activation in endotoxin\u2010induced uveitis","volume":"171","author":"Toguri","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.09.004_bib0035","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3233\/CH-151996","article-title":"Cannabinoid 2 receptor activation reduces leukocyte adhesion and improves capillary perfusion in the iridial microvasculature during systemic inflammation","volume":"61","author":"Toguri","year":"2015","journal-title":"Clin. Hemorheol. Microcirc."},{"issue":"5","key":"10.1016\/j.prostaglandins.2018.09.004_bib0040","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol. Pharmacol."},{"issue":"6441","key":"10.1016\/j.prostaglandins.2018.09.004_bib0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"issue":"5090","key":"10.1016\/j.prostaglandins.2018.09.004_bib0050","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.09.004_bib0055","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.prostaglandins.2018.09.004_bib0060","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","article-title":"A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol","volume":"14","author":"Blankman","year":"2007","journal-title":"Chem. Biol."},{"issue":"6604","key":"10.1016\/j.prostaglandins.2018.09.004_bib0065","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.09.004_bib0070","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1096\/fj.08-108670","article-title":"The GPR55 ligand L-\u03b1-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation","volume":"23","author":"Henstridge","year":"2009","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.prostaglandins.2018.09.004_bib0075","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2018.09.004_bib0080","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2202-11-44","article-title":"N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor","volume":"11","author":"McHugh","year":"2010","journal-title":"BMC Neurosci."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.09.004_bib0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-2187-7-10","article-title":"siRNA knockdown of GPR18 receptors in BV-2 microglia attenuates N-arachidonoyl glycine-induced cell migration","volume":"7","author":"McHugh","year":"2012","journal-title":"J. Mol. Signal."},{"issue":"8","key":"10.1016\/j.prostaglandins.2018.09.004_bib0090","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1111\/j.1476-5381.2011.01497.x","article-title":"Delta(9) -Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells","volume":"165","author":"McHugh","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"16","key":"10.1016\/j.prostaglandins.2018.09.004_bib0095","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1111\/bph.12746","article-title":"Activation of GPR18 by cannabinoid compounds: a tale of biased agonism","volume":"171","author":"Console\u2010Bram","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2018.09.004_bib0100","doi-asserted-by":"crossref","DOI":"10.1242\/bio.20149571","article-title":"TRPV1 mediates cellular uptake of anandamide and thus promotes endothelial cell proliferation and network-formation","author":"Hofmann","year":"2014","journal-title":"Biol. Open"},{"key":"10.1016\/j.prostaglandins.2018.09.004_bib0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fncel.2014.00195","article-title":"Novel endogenous N-acyl amides activate TRPV1-4 receptors, BV-2 microglia, and are regulated in brain in an acute model of inflammation","volume":"8","author":"Raboune","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"4","key":"10.1016\/j.prostaglandins.2018.09.004_bib0110","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB(1) and CB(2)","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol. Rev."},{"issue":"2-3","key":"10.1016\/j.prostaglandins.2018.09.004_bib0115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1054\/plef.2001.0341","article-title":"Cannabinoid receptors and their ligands","volume":"66","author":"Pertwee","year":"2002","journal-title":"Prostagland. Leukotrienes Essent. Fatty Acids (PLEFA)"},{"key":"10.1016\/j.prostaglandins.2018.09.004_bib0120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.phrs.2016.04.020","article-title":"Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain","volume":"110","author":"Leishman","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"60","key":"10.1016\/j.prostaglandins.2018.09.004_bib0125","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.bbalip.2016.03.003","article-title":"Lipidomics profile of a NAPE-PLD KO mouse provides evidence of a broader role of this enzyme in lipid metabolism in the brain","volume":"1861","author":"Leishman","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.prostaglandins.2018.09.004_bib0130","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1167\/iovs.16-19356","article-title":"Harnessing the endocannabinoid 2-arachidonoylglycerol to lower intraocular pressure in a murine ModelLower IOP with endocannabinoid 2-Arachidonoylglycerol","volume":"57","author":"Miller","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"14","key":"10.1016\/j.prostaglandins.2018.09.004_bib0135","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.1167\/iovs.16-19437","article-title":"Evidence for a GPR18 role in diurnal regulation of intraocular PressureA GPR18 role in diurnal variation of IOP","volume":"57","author":"Miller","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.prostaglandins.2018.09.004_bib0140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/bs.mie.2017.06.024","article-title":"Lipidomics: a corrective Lens for enzyme myopia","volume":"593","author":"Bradshaw","year":"2017","journal-title":"Methods Enzymol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2018.09.004_bib0145","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3129\/i10-069","article-title":"Canadian Ophthalmological Society policy statement on the medical use of marijuana for glaucoma","volume":"45","author":"Buys","year":"2010","journal-title":"Can. J. Ophthalmol.\/J. Can. d\u2019Ophtalmol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.09.004_bib0150","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S2173-5794(11)70004-4","article-title":"Cannabinoid applications in glaucoma","volume":"86","author":"Pinar-Sueiro","year":"2011","journal-title":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.09.004_bib0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0022-1759(00)00165-4","article-title":"Digital video-imaging of leukocyte migration in the iris: intravital microscopy in a physiological model during the onset of endotoxin-induced uveitis","volume":"240","author":"Becker","year":"2000","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.prostaglandins.2018.09.004_bib0160","doi-asserted-by":"crossref","first-page":"436252","DOI":"10.1155\/2013\/436252","article-title":"Brain levels of prostaglandins, endocannabinoids, and related lipids are affected by mating strategies","volume":"2013","author":"Stuart","year":"2013","journal-title":"Int. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.09.004_bib0165","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1471-4159.2005.03380.x","article-title":"Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli","volume":"95","author":"Maresz","year":"2005","journal-title":"J. Neurochem."},{"issue":"30","key":"10.1016\/j.prostaglandins.2018.09.004_bib0170","doi-asserted-by":"crossref","first-page":"9007","DOI":"10.1021\/bi0608008","article-title":"A FAAH-regulated class of N-acyl taurines that activates TRP ion channels","volume":"45","author":"Saghatelian","year":"2006","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.09.004_bib0175","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1189\/jlb.0111036","article-title":"Endotoxin-induced uveitis is primarily dependent on radiation-resistant cells and on MyD88 but not TRIF","volume":"90","author":"Kezic","year":"2011","journal-title":"J. Leukoc. Biol."},{"issue":"9","key":"10.1016\/j.prostaglandins.2018.09.004_bib0180","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.1167\/iovs.11-7742","article-title":"Contrasting ocular effects of local versus systemic endotoxin","volume":"52","author":"Rosenbaum","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.prostaglandins.2018.09.004_bib0185","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0014-4835(05)80056-9","article-title":"Endotoxin induced uveitis in the mouse: susceptibility and genetic control","volume":"61","author":"Li","year":"1995","journal-title":"Exp. Eye Res."},{"issue":"5773","key":"10.1016\/j.prostaglandins.2018.09.004_bib0190","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/286611a0","article-title":"Endotoxin-induced uveitis in rats as a model for human disease","volume":"286","author":"Rosenbaum","year":"1980","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.09.004_bib0195","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-2999(00)00211-9","article-title":"Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB 2 receptor","volume":"396","author":"Buckley","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.prostaglandins.2018.09.004_bib0200","doi-asserted-by":"crossref","first-page":"e6409","DOI":"10.1371\/journal.pone.0006409","article-title":"CB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis","volume":"4","author":"Cs\u00f3ka","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.09.004_bib0205","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4049\/jimmunol.0900203","article-title":"The cannabinoid receptor 2 is critical for the host response to sepsis","volume":"183","author":"Tsch\u00f6p","year":"2009","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.prostaglandins.2018.09.004_bib0210","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1523\/JNEUROSCI.4628-11.2012","article-title":"Activation of cannabinoid receptor 2 attenuates leukocyte\u2013endothelial cell interactions and blood\u2013brain barrier dysfunction under inflammatory conditions","volume":"32","author":"Ramirez","year":"2012","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.prostaglandins.2018.09.004_bib0215","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.ajpath.2013.07.033","article-title":"Selective activation of cannabinoid receptor 2 in leukocytes suppresses their engagement of the brain endothelium and protects the blood-brain barrier","volume":"183","author":"Rom","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.09.004_bib0220","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.mvr.2009.03.005","article-title":"CB 2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic\/reperfusion injury","volume":"78","author":"Zhang","year":"2009","journal-title":"Microvasc. Res."},{"issue":"3","key":"10.1016\/j.prostaglandins.2018.09.004_bib0225","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11481-013-9445-9","article-title":"Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation","volume":"8","author":"Rom","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"5","key":"10.1016\/j.prostaglandins.2018.09.004_bib0230","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000055678","article-title":"Thalidomide inhibits leukocyte-endothelium interaction in endotoxin-induced uveitis","volume":"33","author":"Baatz","year":"2001","journal-title":"Ophthalmic Res."},{"issue":"10","key":"10.1016\/j.prostaglandins.2018.09.004_bib0235","first-page":"1949","article-title":"Endotoxin-induced uveitis. Kinetics and phenotype of the inflammatory cell infiltrate and the response of the resident tissue macrophages and dendritic cells in the iris and ciliary body","volume":"36","author":"McMenamin","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.09.004_bib0240","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10753-007-9055-x","article-title":"Characterizing extravascular neutrophil migration in vivo in the iris","volume":"31","author":"Planck","year":"2008","journal-title":"Inflammation"},{"issue":"9","key":"10.1016\/j.prostaglandins.2018.09.004_bib0245","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1076\/ceyr.17.9.941.5139","article-title":"The effect of genetic deficiency of adhesion molecules on the course of endotoxin-induced uveitis","volume":"17","author":"Planck","year":"1998","journal-title":"Curr. Eye Res."},{"issue":"3","key":"10.1016\/j.prostaglandins.2018.09.004_bib0250","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1096\/fj.09-141275","article-title":"Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment","volume":"24","author":"Murikinati","year":"2010","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.09.004_bib0255","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/157015907780866884","article-title":"The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration","volume":"5","author":"Ashton","year":"2007","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.09.004_bib0260","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1567-5769(01)00147-3","article-title":"Differential expression of the CB 2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation","volume":"2","author":"Carlisle","year":"2002","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.09.004_bib0265","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neulet.2008.08.076","article-title":"Cannabinoid receptor 2 is increased in acutely and chronically inflamed bladder of rats","volume":"445","author":"Merriam","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.prostaglandins.2018.09.004_bib0270","doi-asserted-by":"crossref","first-page":"H2210","DOI":"10.1152\/ajpheart.00688.2007","article-title":"CB 2-receptor stimulation attenuates TNF-\u03b1-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion","volume":"293","author":"Rajesh","year":"2007","journal-title":"Am. J. Physiol.\u2013Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.09.004_bib0275","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2377-6-12","article-title":"COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells\/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord","volume":"6","author":"Yiangou","year":"2006","journal-title":"BMC Neurol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2018.09.004_bib0280","doi-asserted-by":"crossref","first-page":"E99","DOI":"10.1208\/pt070496","article-title":"Aqueous, oil, and ointment formulations of ketorolac: efficacy against prostaglandin E2-induced ocular inflammation and safety: a technical note","volume":"7","author":"Malhotra","year":"2006","journal-title":"AAPS PharmSciTech"},{"issue":"12","key":"10.1016\/j.prostaglandins.2018.09.004_bib0285","doi-asserted-by":"crossref","first-page":"E1469","DOI":"10.1152\/ajpendo.00269.2012","article-title":"Regulation of GPR119 receptor activity with endocannabinoid-like lipids","volume":"303","author":"Syed","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.prostaglandins.2018.09.004_bib0290","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1167\/iovs.16-21330","article-title":"A GPR119 signaling system in the murine eye regulates intraocular pressure in a sex-dependent MannerGPR119 regulates intraocular pressure","volume":"58","author":"Miller","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3\u20134","key":"10.1016\/j.prostaglandins.2018.09.004_bib0295","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.prostaglandins.2009.07.001","article-title":"Receptors for acylethanolamides-GPR55 and GPR119","volume":"89","author":"Godlewski","year":"2009","journal-title":"Prostaglandins Other Lipid Mediat."}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109888231830025X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109888231830025X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T12:48:54Z","timestamp":1751892534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109888231830025X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":59,"alternative-id":["S109888231830025X"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2018.09.004","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation and CB2 signaling drive novel changes in the ocular lipidome and regulate immune cell activity in the eye","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2018.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}